Navigation Links
Marken Expands Regulatory And Technical Excellence In Logistics

RESEARCH TRIANGLE PARK, N.C., Jan. 30, 2013 /PRNewswire/ -- Marken today announced the expansion of its internal regulatory and technical expertise with the promotion of Dan Bell to Vice President.  The announcement follows an industry-led panel discussion hosted by Marken in Farmingdale, New York on January 15th.  The panel was convened to shed light on the growing complexity of clinical supply chain management.  Industry experts shared a wide range of perspectives relating to clinical trials risk, cost, resources and security.

(Logo: )

Rafik Bishara , Ph.D., current Chair of the Pharmaceutical Cold Chain Interest Group (PCCIG) within the Parenteral Drug Association (PDA), said: "There is a very clear shift in how we should view 'cold chain' logistics, especially with the growth of biologically derived drugs and vaccines.  Supplier's Quality Systems will need to be expanded to include increased tracking for chain of custody assurance, more reliable data monitoring and compliance with changing customs requirements in developing countries. This shift will go far beyond our current understanding and application of Good Distribution Practices."  The panel was moderated by Pfizer's Bruce Guenter , who said: "Our industry will certainly demand more reliable monitoring of data and will need to ensure compliance with the changing regulations.  It is vital to our industry that we continue to coordinate collaborative exchanges like this to ensure that we are ready, prepared, and ahead of the curve." 

Marken has long been known for its high quality, compliant and reliable service to the pharmaceutical industry.  A new unit has been formed, expanding on Marken's already strong legacy of compliance, and has promoted Dan Bell to a newly created position of Vice President, Regulatory Compliance and Technical Affairs. Wes Wheeler , Marken's CEO, said: "Dan has been instrumental to Marken's growth and has developed strong relationships with some of the industry's most demanding clients.  He is recognized in the industry as a frequent speaker on important issues in cold chain logistics and regulatory challenges.  He is passionate about advancing new techniques, finding solutions and expanding the knowledge base in clinical logistics."

Mr. Bell is also a licensed customs broker and a certified customs specialist in the United States.  He will join Marken's Executive Committee and work with Marken to set objectives for 2013 and beyond.

About Marken
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies.

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
2. Marken Opens Branch Office In Seoul, South Korea
3. Marken Announces Global Advisory Board
4. Marken Launches New Global Regulatory Consultation Services
5. Marken Enhances Branch Operations
6. As Smartphone Usage Expands, Survey Says Nurses and Nursing Students Want Mobile Access to Credible Drug Data
7. BioSurplus Expands, Debuts New 8000 Square Foot Warehouse and Service Facility
8. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
9. Clinical Interest in BioElectronics Products Expands to the Wound Care Market
10. S1 Biopharma Expands Focus to Include Male Sexual Health
11. PRA Expands Operations in Europe
Post Your Comments:
(Date:11/26/2015)... Bajos, November 26, 2015 Un ... de Bremachlorin para el cáncer avanzado.   ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Cancer Research . --> Clinical Cancer Research ...
(Date:11/26/2015)... , November 26, 2015 --> ... to use SyMRI to find optimal contrast weighting of MRI ... metastases, and has signed a research agreement with SyntheticMR in ... hospital. Using SyMRI, it is possible to generate multiple contrast ... after the patient has left, thus making it possible to ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has released ... Surviving Mesothelioma has just posted the findings on the website. Click here to ... cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP surgery. ...
(Date:11/27/2015)... ... 27, 2015 , ... The print component of “Supporting Our ... Dallas, New York, Minneapolis, South Florida, with a circulation of approximately 250,000 copies ... a vast social media strategy and across a network of top news sites ...
(Date:11/27/2015)... DE (PRWEB) , ... November 27, 2015 , ... ... member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s ... an independent group of Microsoft Dynamics SL software users, partners, industry experts and ...
(Date:11/27/2015)... , ... November 27, 2015 , ... CBD College ... of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. ... accredited colleges, as only one of twelve colleges and universities in the state of ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer and distributor ... Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. , ... up-to-date with a version of Asterisk that will receive not only security fixes, ...
Breaking Medicine News(10 mins):